跳至主要内容
临床试验/NCT03891394
NCT03891394Unknown不适用

Prognostic Value of Human Epididymis Protein 4 (HE4) for Persistent Proteinuria in Women With Severe Preeclampsia / HELLP Syndrome

Ain Shams University0 个研究点目标入组 110 人开始时间: 2019年4月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
110
主要终点
protein in urine

研究概览

简要总结

Pre-eclampsia seems to be associated with a four to five times increase risk of later microalbuminuria and CKD which might suggest a possible direct renal damage from pre-eclampsia

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Pregnant women 18-35 years old.
  • Fulfilling the criteria for diagnosis of sever preeclampsia.
  • Fulfilling the criteria for diagnosis of HELLP syndrome

排除标准

  • Diabetes mellitus
  • Preexisting renal disease.
  • Chronic hypertension
  • Rheumatologic diseases
  • Adnexal mass.

结局指标

主要结局

protein in urine

时间窗: 12 weeks postpartum

proteinuria \> 0.3 mg protein / mg creatinine.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Radwa Rasheedy Ali

principal investigator

Ain Shams University

相似试验

Human Epididymis Protein 4 in Women With Severe... | 临床试验